A randomized, placebo-controlled, double-blinded cross-over study of the pharmacologic action of a GPR119 agonist on glucagon counter-regulation during insulin-induced hypoglycemia in Type 1 diabetes mellitus Grant

grant funder

  • Helmsley Charitable Trust

grant sponsor

  • AdventHealth

date/time interval

  • April 1, 2020 - September 30, 2021

local award ID

  • G-2010-04134

contributor

additional investigators

  • Anna Casu, MD